Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein REL.

Leeman JR, Weniger MA, Barth TF, Gilmore TD.

Oncogene. 2008 Dec 4;27(53):6770-81. doi: 10.1038/onc.2008.284. Epub 2008 Aug 11.

PMID:
18695674
[PubMed - indexed for MEDLINE]
Free PMC Article
2.
3.
4.

Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.

Epinat JC, Kazandjian D, Harkness DD, Petros S, Dave J, White DW, Gilmore TD.

Oncogene. 2000 Feb 3;19(5):599-607.

PMID:
10698504
[PubMed - indexed for MEDLINE]
Free Article
5.

Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.

Starczynowski DT, Trautmann H, Pott C, Harder L, Arnold N, Africa JA, Leeman JR, Siebert R, Gilmore TD.

Oncogene. 2007 Apr 26;26(19):2685-94. Epub 2006 Oct 30.

PMID:
17072339
[PubMed - indexed for MEDLINE]
6.

Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells.

Starczynowski DT, Reynolds JG, Gilmore TD.

Oncogene. 2003 Oct 9;22(44):6928-36.

PMID:
14534540
[PubMed - indexed for MEDLINE]
7.
8.

Characterization of a human REL-estrogen receptor fusion protein with a reverse conditional transforming activity in chicken spleen cells.

Kalaitzidis D, Ok J, Sulak L 2nd, Starczynowski DT, Gilmore TD.

Oncogene. 2004 Sep 30;23(45):7580-7.

PMID:
15326488
[PubMed - indexed for MEDLINE]
10.

Transformation by the vRel oncoprotein requires sequences carboxy-terminal to the Rel homology domain.

Sarkar S, Gilmore TD.

Oncogene. 1993 Aug;8(8):2245-52.

PMID:
8336947
[PubMed - indexed for MEDLINE]
11.

Repression of B-cell linker (BLNK) and B-cell adaptor for phosphoinositide 3-kinase (BCAP) is important for lymphocyte transformation by rel proteins.

Gupta N, Delrow J, Drawid A, Sengupta AM, Fan G, Gélinas C.

Cancer Res. 2008 Feb 1;68(3):808-14. doi: 10.1158/0008-5472.CAN-07-3169.

PMID:
18245482
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.

Sif S, Capobianco AJ, Gilmore TD.

Oncogene. 1993 Sep;8(9):2501-9.

PMID:
8361761
[PubMed - indexed for MEDLINE]
13.

CAPERalpha is a novel Rel-TAD-interacting factor that inhibits lymphocyte transformation by the potent Rel/NF-kappaB oncoprotein v-Rel.

Dutta J, Fan G, Gélinas C.

J Virol. 2008 Nov;82(21):10792-802. doi: 10.1128/JVI.00903-08. Epub 2008 Aug 27.

PMID:
18753212
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel.

Mosialos G, Hamer P, Capobianco AJ, Laursen RA, Gilmore TD.

Mol Cell Biol. 1991 Dec;11(12):5867-77.

PMID:
1944267
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Conservation and expression of an alternative 3' exon of Runx2 encoding a novel proline-rich C-terminal domain.

Terry A, Kilbey A, Vaillant F, Stewart M, Jenkins A, Cameron E, Neil JC.

Gene. 2004 Jul 7;336(1):115-25.

PMID:
15225881
[PubMed - indexed for MEDLINE]
16.
17.

Transactivation of gene expression by nuclear and cytoplasmic rel proteins.

Hannink M, Temin HM.

Mol Cell Biol. 1989 Oct;9(10):4323-36.

PMID:
2555689
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Mapping of a serine-rich domain essential for the transcriptional, antiapoptotic, and transforming activities of the v-Rel oncoprotein.

Chen C, Agnès F, Gélinas C.

Mol Cell Biol. 1999 Jan;19(1):307-16.

PMID:
9858554
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP).

Chang CH, Scott GK, Baldwin MA, Benz CC.

Oncogene. 1999 Jun 24;18(25):3682-95.

PMID:
10391676
[PubMed - indexed for MEDLINE]
Free Article
20.

vRel is an inactive member of the Rel family of transcriptional activating proteins.

Richardson PM, Gilmore TD.

J Virol. 1991 Jun;65(6):3122-30.

PMID:
1903456
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk